Effect of internet-delivered exposure therapy versus healthy lifestyle promotion for patients with persistent physical symptoms (SOMEX1): a randomized controlled trial with planned moderator analysis
Exposure therapy does not appear to show noteworthy average benefit over HLP, with the exception of symptom preoccupation. Substantial benefits are seen in patients with very high symptom burden or symptom preoccupation.
Authors
- Eva Toth-Pal (ORCID: https://orcid.org/0000-0001-7721-3272)
- Majken Epstein (ORCID: https://orcid.org/0000-0001-8397-5986)
- Caroline Wachtler (ORCID: https://orcid.org/0000-0002-1317-7732)
- Daniel Björkander
- Sandra af Winklerfelt Hammarberg (ORCID: https://orcid.org/0000-0001-5873-1568)
- Erland Axelsson (ORCID: https://orcid.org/0000-0003-2562-2925)
- Amanda Kosic (ORCID: https://orcid.org/0000-0001-7975-4558)
- John Wallert (ORCID: https://orcid.org/0000-0002-1473-4916)
- Sigrid Salomonsson (ORCID: https://orcid.org/0000-0002-6713-5933)
- Steven Nordin (ORCID: https://orcid.org/0000-0003-1699-1681)
- Eva K. Strand (ORCID: https://orcid.org/0000-0003-3968-6671)
- Jonna Hybelius (ORCID: https://orcid.org/0000-0002-1593-3431)
- Anna Olsson (ORCID: https://orcid.org/0000-0001-9661-491X)
- L. De Winter
- Gabriel Chahin
- Tomas Åkerlund
Institutions
- Örebro University (SE)
- Karolinska Institutet (SE)
- Stockholm Health Care Services (SE)
- Institute of Neurobiology (BG)
- Umeå University (SE)
Publication Details
- Journal
- Psychological Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/s0033291725101244
- Citations
- 1
- Primary Topic
- Psychosomatic Disorders and Their Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.47
Funders
- Karolinska Institutet